Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL

NCT00041288 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Poor accrual and difficulty with multicenter logistics

Conditions

Leukemia
Lymphoma

Interventions

BIOLOGICAL: therapeutic allogeneic lymphocytes
DRUG: cyclophosphamide
DRUG: cyclosporine
DRUG: fludarabine phosphate
DRUG: methotrexate
DRUG: mycophenolate mofetil
DRUG: tacrolimus
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: radiation therapy

Sponsor

University of Texas Southwestern Medical Center